Compound Radar

Align Technology, Inc. (ALGN) Stock Analysis

Price $153.49
Market cap $10.90B
Next earnings Oct 28, 2026
Entry status Wait

Last updated Sep 8, 2026

Health Check

Last analyzed Sep 7, 2026

61
61/100 Good Quality
  • Financial Health 60
  • Profitability 60
  • Business Quality 75
  • Balance Sheet 65
  • Cash Flow 45

Why this rating?

Health 61/100 — Good Quality

Strongest Business Quality 75/100
Softest Cash Flow 45/100
Wait

Entry timing is weak right now. Quality may be fine; the setup is not.

Company overview

Align Technology, Inc. (ALGN) is a Medical Instruments & Supplies company in the Healthcare sector. Compound Radar rates Align Technology, Inc. 61/100 (Good Quality) due to high business quality, steady revenue growth, and manageable leverage.

Investment profile

  • Quality High
  • Growth Moderate
  • Balance Sheet Adequate
  • Valuation Attractive

Financial highlights

Valuation

  • P/E 26.65
  • Forward P/E 12.23
  • PEG 0.67
  • EV/Revenue 2.49

Profitability

  • Revenue Growth 4.3%
  • Gross Margin 70.4%
  • Operating Margin 18.2%
  • Net Margin 10.0%
  • ROE 10.2%

Financial strength

  • Cash $1.10B
  • Debt $120.84M
  • Net Cash $981.75M
  • Free Cash Flow $490.78M
  • Current Ratio 1.4

Similar companies

Peers in Medical Instruments & Supplies, ranked by Financial Health.

Company Ticker
Price Current price

Latest quoted price for the name. Helps anchor the setup in today’s market level.

Health Entry

View all in Medical Instruments & Supplies →

FAQ

How Compound Radar scores and tracks Align Technology, Inc. (ALGN).

View Methodology & FAQ →